DREAMCIS, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,010 KRW | +1.52% |
|
+10.26% | -7.53% |
| Sales 2022 | 38.87B 28.22M 0 | Sales 2023 | 47.84B 34.73M 0 | Capitalization | 75.04B 54.48M 0 |
|---|---|---|---|---|---|
| Net income 2022 | 4.4B 3.2M - | Net income 2023 | 3.74B 2.71M - | EV / Sales 2022 | 1.13 x |
| Net cash position 2022 | 17.56B 12.75M 0 | Net cash position 2023 | 16.79B 12.19M 0 | EV / Sales 2023 | 1.22 x |
| P/E ratio 2022 |
13.8
x | P/E ratio 2023 |
20.7
x | Employees | 236 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 28.16% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.52% | ||
| 1 week | +10.26% | ||
| Current month | +0.84% | ||
| 1 month | +0.84% | ||
| 3 months | -0.66% | ||
| 6 months | -12.75% | ||
| Current year | -7.53% |
1 week
2 720.00
3 175.00
1 month
2 610.003 175.00
Current year
2 610.003 475.00
1 year
2 610.009 750.00
3 years
2 370.009 750.00
5 years
2 370.009 750.00
10 years
2 370.009 750.00
| Managers | Title | Age | Since |
|---|---|---|---|
Kyung-Sun Gong
CEO | Chief Executive Officer | 56 | - |
Tae-Sik Yang
DFI | Director of Finance/CFO | 55 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Kyung-Sun Gong
CEO | Chief Executive Officer | 56 | - |
Nam-Hoon Kim
BRD | Director/Board Member | 43 | - |
Tae-Sik Yang
DFI | Director of Finance/CFO | 55 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-30 | 3,010 | +1.52% | 577,794 |
| 24-04-29 | 2,965 | -.--% | 107,587 |
| 24-04-26 | 2,965 | +0.68% | 276,549 |
| 24-04-25 | 2,945 | +6.13% | 1,467,301 |
| 24-04-24 | 2,775 | +2.40% | 116,911 |
End-of-day quote Korea S.E., April 29, 2024
More quotes
DreamCIS Inc is a Korea-based company principally engaged in the business of contract clinical trial. The Company mainly provides services include regulatory post-marketing surveillance (rPMS), clinical trial, non-interventional study (NIS) and others. The Company provides its services within domestic market and to overseas markets.
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -7.53% | 50.15M | |
| -18.98% | 8.22B | |
| +45.10% | 3.73B | |
| -8.06% | 2.46B | |
| -38.71% | 2.46B | |
| -7.57% | 2.36B | |
| -13.72% | 1.78B | |
| -19.73% | 1.52B | |
| -40.78% | 1.21B | |
| +8.32% | 1.12B |
- Stock Market
- Equities
- A223250 Stock
